For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
Publishing research using ab47816? Please let us know so that we can cite the reference in this datasheet.
ab47816 has been referenced in 1 publication.
- Shirakawa K et al. Salicylate, diflunisal and their metabolites inhibit CBP/p300 and exhibit anticancer activity. Elife 5:N/A (2016).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"